Replies to post #53486 on Arrayit Corporation (ARYC)

[Alyssa]

1. Why would anyone pay for a negative promotion? lol

2. We all know about that, which is why I didn't post the entire article.

3. If Avant benefits from the sale of OvaDx, then so should ARYC. "Under the settlement, Arrayit retained the right to manufacture the OvaDx test, and Avant retained its right to sell and market OvaDx upon US Food and Drug Administration clearance."

4. As I have said before that 10% could mean an expotential growth over a few years, not a fixed annual percentage. It's sort of silly to expect their business to shrink or stay the same rather than grow with the demand.